Companion Animals

Dog Canine Atopy Research Advances

Research advances in canine atopic dermatitis are improving understanding of disease mechanisms and enabling development of better treatments.

Key Facts

IL-31 has been identified as the primary itch mediator in canine atopic dermatitis
Skin microbiome dysbiosis contributes to barrier dysfunction and allergen sensitization
Genome-wide association studies have identified genetic risk loci in predisposed breeds
Monoclonal antibody therapies targeting specific cytokine pathways show superior efficacy
Novel JAK inhibitor formulations with improved safety profiles are in clinical development

Welfare Considerations

Research advances in atopic dermatitis are leading directly to better treatments that more effectively control itch with fewer side effects. Translation of research advances into clinical practice improves welfare for millions of dogs affected by this chronic condition.

What You Can Do

Discuss current best-practice treatments with a veterinary dermatologist annually
Support veterinary dermatology research that continues to advance atopy management
Participate in clinical trials if your dog is eligible, contributing to research that benefits future patients